Abstract

Summary Total protein (tp), albumin, and IgG concentrations were measured in csf from the atlanto-occipital (ao) and lumbosacral (ls) sites and in serum of 15 clinically normal neonatal foals ≤ 10 days old (mean, 7.0 days). The albumin quotient (aq; csf albumin/serum albumin × 100) and IgG index ([csf IgG/serum IgG] × [serum albumin/csf albumin]), indicators of blood-brain barrier permeability and intrathecal IgG production, respectively, were then calculated. Mean ± sd values obtained from the foals of this study were: serum albumin, 2,900 ± 240 mg/dl; serum IgG, 1,325 ± 686 mg/dl; ao csf total protein (tp), 82.8 ± 19.2 mg/dl; ls csf tp, 83.6 ± 16.1 mg/dl; ao csf albumin, 52.0 ± 8.6 mg/dl; ls csf albumin, 53.8 ± 15.7 mg/dl; ao csf IgG, 10.2 ± 5.5 mg/dl; ls csf IgG, 9.9 ± 5.7 mg/dl; ao aq, 1.86 ± 0.29; ls aq, 1.85 ± 0.51, ao IgG index, 0.52 ± 0.28; and ls IgG index, 0.48 ± 0.27. Significant difference between values for the ao and ls sites was not found. A csf albumin concentration > 85.2 mg/dl or aq > 2.4, as determined by mean ± 2 sd, may indicate increased blood-brain barrier permeability. An IgG index value >1.0 may indicate intrathecal IgG production. Values obtained for foals of this study should serve as baseline for comparison in the evaluation of blood-brain barrier permeability and intrathecal IgG production in neonatal foals with neurologic disease.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.